Fosamprenavir Calcium Tablet, Coated
Product Images NDC 63304-583

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fosamprenavir Calcium (NDC 63304-583). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image1 (Fosamgraph)

This text appears to be providing dosing information for different forms of medication with the brand name LEXNA, LEXIVA, LEXVA, and LEXA. The dosages mentioned include 1400 g once daily, 200 mg once daily, 700 mg twice daily with ritonavir 100 mg twice daily for 24 individuals, 1400 mg twice daily for 22 individuals, and 1400 mg once daily with ritonavir 100 mg once daily for 35 individuals. It is not clear what type of medication this is and for what medical condition it is used.*

FDA Label Image

Structure (Fosamstr)

FDA Label Image

Spl-fosamprenavir-bottle-label (Spl Fosamprenavir Bottle Label)

The text provides information about NDC 63304-583-60 which is Fosamprenavir Calcium tablets in the form of 60 tablets. It also includes an alert to inquire about medications that should not be taken with Fosamprenavir Calcium tablets. The note advises not to cover the ALERT box with a pharmacy label.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.